Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response

被引:101
|
作者
Hofmann, P [1 ]
Sprenger, H [1 ]
Kaufmann, A [1 ]
Bender, A [1 ]
Hasse, C [1 ]
Nain, M [1 ]
Gemsa, D [1 ]
机构
[1] UNIV MARBURG, INST IMMUNOL, D-35037 MARBURG, GERMANY
关键词
chemokines; apoptosis; chemotaxis; nuclear factor-kappa B; cytokine gene transcription;
D O I
10.1002/jlb.61.4.408
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Among leukocytes, only monocytes and macrophages were found to be highly susceptible to an infection by influenza A virus. After infection, de novo viral protein synthesis was initiated but then interrupted after 4-6 h. Most macrophages died by apoptosis within 25-30 h. Before cell death, however, macrophages responded to influenza A virus with a high cytokine gene transcription and subsequent release of tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), IL-6, interferon (IFN)-alpha/beta, and CC-chemokines. The basic mechanisms of virus-induced cytokine expression are still unknown and appear to involve transcription factors such as nuclear factor-kappa B and AP-1 which, however, were only activated for 2 h and declined below control values thereafter. After influenza A virus infection, only the mononuclear cell attracting CC-chemokines macrophage inflammatory protein 1 alpha (MIP-1 alpha), MIP-1 beta, and RANTES were produced while the prototype neutrophil CXC-chemoattractants IL-8 and GRO-alpha were entirely suppressed. This selective induction of CC-chemokines may explain the preferential influx of mononuclear leukocytes into virus-infected tissue. Our data show that monocytes and macrophages represent a primary target for an influenza A virus infection. Thus, the mononuclear phagocyte response leads to a rapid proinflammatory reaction and an enhanced immigration of mononuclear leukocytes, which may condition the infected host for the subsequent virus antigen-specific defense.
引用
收藏
页码:408 / 414
页数:7
相关论文
共 50 条
  • [1] Susceptibility of macrophages to influenza a virus infection and possible role in antiviral response.
    Gemsa, D
    JOURNAL OF LEUKOCYTE BIOLOGY, 1996, : 301 - 301
  • [2] The role of mononuclear phagocytes in Ebola virus infection
    Rogers, Kai J.
    Maury, Wendy
    JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 104 (04) : 717 - 727
  • [3] Respiratory Mononuclear Phagocytes in Human influenza A virus infection: Their Role in immune Protection and As Targets of the virus
    Vangeti, Sindhu
    Yu, Meng
    Smed-Sorensen, Anna
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] Characterization of mononuclear phagocytes in the human nasopharynx during Influenza A virus infection
    Vangeti, Sindhu
    Yu, Meng
    Liu, Sang
    Falck, Sara
    Sonden, Klara
    Johansson, Niclas
    Farnert, Anna
    Sorensen, Anna Smed
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 279 - 279
  • [5] ROLE OF MONONUCLEAR PHAGOCYTES IN THE PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    MELTZER, MS
    SKILLMAN, DR
    GOMATOS, PJ
    KALTER, DC
    GENDELMAN, HE
    ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 : 169 - 194
  • [6] INFLUENZA-VIRUS REPLICATION IN DIFFERENTIATING MONONUCLEAR PHAGOCYTES
    ARMSTRONG, JA
    APFELROTH, SD
    NOWAKOWSKI, M
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 625 - 625
  • [7] Mucosal Reactive Oxygen Species Are Required for Antiviral Response: Role of Duox in Influenza A Virus Infection
    Strengert, Monika
    Jennings, Richard
    Davanture, Suzel
    Hayes, Patti
    Gabriel, Guelsah
    Knaus, Ulla G.
    ANTIOXIDANTS & REDOX SIGNALING, 2014, 20 (17) : 2695 - 2709
  • [8] STUDIES ON THE ROLE OF MONONUCLEAR PHAGOCYTES IN RESISTANCE TO ACUTE LYMPHOCYTIC CHORIOMENINGITIS VIRUS-INFECTION
    THOMSEN, AR
    VOLKERT, M
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1983, 18 (04) : 271 - 277
  • [9] The role of the antibody response in influenza virus infection
    Gerhard, W
    ANTIBODIES IN VIRAL INFECTION, 2001, 260 : 171 - 190
  • [10] The role of modern antiviral therapy in prophylaxis and therapy of influenza virus infection
    Grünewald, T
    Waizmann, M
    Schulze, MH
    Ruf, BR
    MEDIZINISCHE WELT, 2001, 52 (05): : 121 - 125